Clinical Trials

Prostatic Neoplasms

NCT05264337 2026-01-16

Lymphedema After Urologic Surgery

400 enrolled

Urinary Bladder Neoplasms, Lymphedema, Penile Neoplasms, Prostatic Neoplasms, Testicular Neoplasms

NCT07181122 2025-11-24

PRO-MIND

102 enrolled

Depression, Fatigue, Sleep Initiation and Maintenance Disorders, Prostatic Neoplasms

NCT07037589 2025-11-21

BLUSH

300 enrolled

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Hematuria, Kidney Neoplasms

NCT06773806 2025-09-19

CHLOECAPA

Not yet recruiting

3,600 enrolled

Prostatic Neoplasms

NCT07180121 2025-09-18

CaRe

Enrolling by invitation

200 enrolled

Urinary Bladder Neoplasms

NCT03967080 2025-09-03

ARPC-MRI

5 enrolled

Prostatic Neoplasms

NCT06687421 2025-09-03

SPRINTR-REAL

5,500 enrolled

Prostatic Neoplasms

NCT06359717 2025-08-14

PSMA-RADS

Active not recruiting

477 enrolled

Prostatic Neoplasms

NCT02358980 2025-06-25

KEEPER

5 enrolled

GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT03982095 2025-06-20

PCa_LS

Motor Activity, Prostatic Neoplasms, Health Behavior, Sedentary Behavior

NCT06941038 2025-04-23

IEPBR

270 enrolled

Urinary Bladder Neoplasms

NCT06863090 2025-03-11

In Vivo Dosimetry for Brachytherapy Study

20 enrolled

Prostatic Neoplasms

NCT06507462 2025-02-11

A Diagnostic Prediction Model for Prostate Cancer in Patients With PI-RADS Score 3

460 enrolled

Disease, Prostatic Neoplasms

NCT06612047 2025-02-11

5TbpMRI

150 enrolled

Disease, Prostatic Neoplasms

NCT06737588 2025-02-11

The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer

600 enrolled

Disease, Prostatic Neoplasms

NCT06719232 2024-12-12

NOCATIN

300 enrolled

Cystitis, Hemorrhagic, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Cystitis, Urinary Tract Infections, Cystitis, Interstitial

NCT06607809 2024-10-08

IMNR

99 enrolled

Carcinoma, Renal Cell

NCT06358599 2024-04-10

The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy

221 enrolled

Urinary Bladder Neoplasms

NCT05940415 2024-01-31

ASWBP

220 enrolled

Prostatic Neoplasms

NCT06116851 2023-11-03

PROMIC

300 enrolled

Prostatic Hyperplasia, Prostatic Neoplasms

NCT06029088 2023-09-08

Risk-adapted Strategy Including Magnetic Resonance Imaging and Prostate-specific Antigen Density in Blood for Biopsy Decision in Patients With Lesions Suspicious for Prostate Cancer

616 enrolled

Prostatic Neoplasms

NCT03948204 2023-09-01

Quality of Life and Shared Decision Making in Prostate Cancer

10,000 enrolled

Prostatic Neoplasms

NCT05941104 2023-07-12

The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical Prostatectomy

100 enrolled

Frailty, Prostatic Neoplasms

NCT03381105 2023-04-24

PSA2STHLM3/1

Active not recruiting

13,431 enrolled

Prostatic Neoplasms

NCT05460312 2023-01-26

Protein Kinase A in Prostate Cancer Tissue.

100 enrolled

Inflammation, Prostatic Hyperplasia, Prostatic Neoplasms

NCT05671263 2023-01-09

Genital Lichen Sclerosus - Epidemiology, Comorbidities and the Role of Vulvar and Penile Microbiome

200 enrolled

GenitourinaryGynecologic

Penile Neoplasms, Vulvar Neoplasms, Lichen Sclerosus et Atrophicus

NCT05467267 2022-07-20

Personalized Urine Biomarker for Patients With Bladder Cancer

20 enrolled

Urinary Bladder Neoplasms

NCT04339933 2022-04-07

Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma

92 enrolled

Urinary Bladder Neoplasms

NCT05290623 2022-03-22

High-power Green-light Laser Endoscopic Submucosal Dissection for Non-muscle-invasive Bladder Cancer

45 enrolled

Urinary Bladder Neoplasms

NCT05134623 2021-12-16

Smurf2 Gene Expression in Urinary Tract Tumors

50 enrolled

Urinary Bladder Neoplasms

NCT04523025 2020-11-25

NorCys-NLR

230 enrolled

Urinary Bladder Neoplasms

NCT04523038 2020-11-25

NorCys-Alb

1,700 enrolled

Urinary Bladder Neoplasms

NCT04537221 2020-11-25

NorCys-Transf

1,700 enrolled

Urinary Bladder Neoplasms

NCT04278443 2020-02-20

Fertility After Prostate Brachytherapy

Prostatic Neoplasms

NCT03256877 2019-07-29

TransTuFo

750 enrolled

Carcinoma, Transitional Cell

NCT03973307 2019-06-04

UroX Biomarker Bladder Cancer Study

100 enrolled

Urinary Bladder Neoplasms

NCT02013180 2019-04-16

Zinc/PSA Ratio as a Novel Biomarker for Prostate Cancer Detection

480 enrolled 6 charts

GenitourinaryHead & Neck

Salivary Gland Adenoma, Pleomorphic, Prostatic Neoplasms

NCT02761135 2018-05-22

Does End-fire Technique Increase Detection Rate of Prostate Cancer at First Re-biopsy Compared to Side-fire Technique?

364 enrolled

Prostatic Neoplasms

NCT03442075 2018-03-27

Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy

70 enrolled

Prostatic Neoplasms

NCT02031029 2017-03-31

Character Traits and Stress in Suspected Prostate Cancer

Terminated

51 enrolled

Prostatic Diseases

NCT00823771 2017-02-02

PROFUGO

Terminated

107 enrolled

Prostatic Neoplasms

NCT02545881 2016-10-19

PROAG

200 enrolled

Prostatic Neoplasms

NCT02790216 2016-06-03

Deformable Registration of Multi-parametric MRI to Intra-operative Transrectal Ultrasound for Prostate Brachytherapy

24 enrolled

Prostatic Neoplasms

NCT01023529 2015-11-18

PallRad1

GastrointestinalGenitourinary

98 enrolled

Prostatic Neoplasms, Rectal Neoplasms

NCT00930748 2011-06-27

Evaluation of MRI for Prostate Cancer

Terminated

Prostatic Neoplasms

NCT00962052 2010-09-14

Biomarker Discovery and Application in Bladder Cancer

250 enrolled

Urinary Bladder Neoplasms

NCT00536055 2007-09-27

Dyadic Coping in Breast and Prostate Cancer Patients and Their Spouses

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT00524823 2007-09-05

FACS